middle.news
Radiopharm Secures FDA Nod to Launch First-in-Human Trial of RV-01 Targeting Aggressive Tumors
8:43am on Monday 28th of July, 2025 AEST
•
Healthcare
Read Story
Radiopharm Secures FDA Nod to Launch First-in-Human Trial of RV-01 Targeting Aggressive Tumors
8:43am on Monday 28th of July, 2025 AEST
Key Points
FDA grants IND approval for RV-01 Phase I trial
RV-01 targets 4Ig isoform of B7-H3, highly expressed in tumors
First-in-human study planned for Q4 2025
Collaboration with MD Anderson Cancer Center
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Radiopharm Theranostics (ASX:RAD)
OPEN ARTICLE